The Gross Margin of Gene Biotherapeutics Inc (CRXM) is 36.67%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2020-12-31 | 36.67% |
2019-12-31 | 36.67% |
2018-12-31 | 8.85% |